Europe Radiation Oncology Market

Historic Data: 2021-2022   |   Base Year: 2023   |   Forecast Period: 2024-2031

Analysis - by Types (External Beam Radiation Therapy and Internal Beam Radiation Therapy) and Application (Breast Cancer, Prostate Cancer, Lung Cancer, Head & Neck Cancer, Cervical Cancer, and Others)

No. of Pages: 87    |    Report Code: BMIRE00030997    |    Category: Life Sciences

Available Report Formats

pdf-format excel-format pptx-format
Buy Now
Europe Radiation Oncology Market
Free Sample Buy Now

The Europe radiation oncology market was valued at US$ 3,317.21 million in 2023 and is expected to reach US$ 8,723.07 million by 2031; it is estimated to record a CAGR of 12.8% from 2023 to 2031.

Initiatives to Support Developments in Radiation Oncology Drive Europe Radiation Oncology Market



The governments and organizations are introducing missions and programs for the quick and effective treatment of cancer with the use of radiotherapy. In September 2023, the International Atomic Energy Agency (IAEA) announced the "Rays of Hope"-flagship cancer initiative for the development of radiotherapy infrastructure. In developed countries such as the US, Germany, UK, France, and others nearly all patients have access to radiotherapy. In middle-income countries 60% of the patient population and 1 in 10 patients in low-income countries have access to radiotherapy. The "Rays of Hope Cancer Care for All" focuses on the development of radiotherapy services all over the world. Since, launch of the initiative, various countries have received radiotherapy equipment and training required to operate the equipment for timely diagnosis and treatment. All the five continents are involved in the initiative and contributed US$ 45.5 million (Euro 42 million) for the initiative and the private sector invested US$ 768,902 (Euro 710,000) for support. Moreover, manufacturers such as Elekta signed a partnership with IAEA for the improvement of cancer treatment by providing radiotherapy equipment around the world. Additionally, IAEA started training healthcare professionals from different field this includes 14 radiation oncologist, 13 medical physicist, 4 nuclear medicine technologist, 7 nuclear medicine physician, 7 radiopharmacist, 16 radiation therapy technologist, 7 oncology nurses, 4 medical imaging technologist, and 7 radiologists. Therefore, surging initiatives for radiotherapy is expected to increase the penetration in low-income countries along with trained professionals and development in radiotherapy infrastructure is driving the growth of radiation oncology market in coming years.

Europe Radiation Oncology Market Overview



Germany has an advanced healthcare infrastructure with access to cutting-edge technologies that support the implementation of radiotherapy procedures. The country is also renowned for its strong emphasis on innovation and research. Comprehensive cancer centers operating in Germany provide multidisciplinary treatment plans incorporating radiation therapy, surgery, chemotherapy, and other medical procedures. In 2020, Varian announced that the German Cancer Research Center (DKFZ) in Heidelberg ordered an Adaptive Intelligence solution, the first Ethos therapy in the country. This AI-powered, all-encompassing solution aims to improve the efficacy, adaptability, and capacity of radiotherapy.

Europe Radiation Oncology Market Revenue and Forecast to 2031 (US$ Million)

Europe Radiation Oncology Market Revenue and Forecast to 2031 (US$ Million)
Get more information on this report

Europe Radiation Oncology Strategic Insights

Strategic insights for the Europe Radiation Oncology provides data-driven analysis of the industry landscape, including current trends, key players, and regional nuances. These insights offer actionable recommendations, enabling readers to differentiate themselves from competitors by identifying untapped segments or developing unique value propositions. Leveraging data analytics, these insights help industry players anticipate the market shifts, whether investors, manufacturers, or other stakeholders. A future-oriented perspective is essential, helping stakeholders anticipate market shifts and position themselves for long-term success in this dynamic region. Ultimately, effective strategic insights empower readers to make informed decisions that drive profitability and achieve their business objectives within the market.

strategic-framework/europe-radiation-oncology-market-strategic-framework.webp
Get more information on this report

Europe Radiation Oncology Report Scope

Report Attribute Details
Market size in 2023 US$ 3,317.21 Million
Market Size by 2031 US$ 8,723.07 Million
Global CAGR (2023 - 2031) 12.8%
Historical Data 2021-2022
Forecast period 2024-2031
Segments Covered By Types
  • External Beam Radiation Therapy
  • Internal Beam Radiation Therapy
By Application
  • Breast Cancer
  • Prostate Cancer
  • Lung Cancer
  • Head & Neck Cancer
  • Cervical Cancer
Regions and Countries Covered Europe
  • UK
  • Germany
  • France
  • Russia
  • Italy
  • Rest of Europe
Market leaders and key company profiles
  • Varian Medical Systems Inc.
  • Elekta AB.
  • Accuray Incorporated.
  • IBA Worldwide (Ion Beam Applications SA).
  • Becton Dickinson and Co.
  • Nordion.
  • Mevion Medical Systems.
  • NTP RADIOISOTOPES.
  • Mallinckrodt Plc.
  • Curium.
    		•
    Get more information on this report

    Europe Radiation Oncology Regional Insights

    The geographic scope of the Europe Radiation Oncology refers to the specific areas in which a business operates and competes. Understanding local distinctions, such as diverse consumer preferences (e.g., demand for specific plug types or battery backup durations), varying economic conditions, and regulatory environments, is crucial for tailoring strategies to specific markets. Businesses can expand their reach by identifying underserved areas or adapting their offerings to meet local demands. A clear market focus allows for more effective resource allocation, targeted marketing campaigns, and better positioning against local competitors, ultimately driving growth in those targeted areas.

    geography/europe-radiation-oncology-market-geography.webp
    Get more information on this report

    Europe Radiation Oncology Market Segmentation



    The Europe radiation oncology market is categorized into types, application, and country.

    Based on type, the Europe radiation oncology market is bifurcated into external beam radiation therapy and internal beam radiation therapy. The external beam radiation therapy segment held a larger market share in 2023.

    In terms of application, the Europe radiation oncology market is categorized into breast cancer, prostate cancer, lung cancer, head and neck cancer, cervical cancer, and others. The breast cancer segment held the largest market share in 2023.

    By country, the Europe radiation oncology market is segmented into Germany, the UK, France, Spain, Italy, and the Rest of Europe. Germany dominated the Europe radiation oncology market share in 2023.

    Varian Medical Systems Inc, Elekta AB, Accuray Incorporated, IBA Worldwide (Ion Beam Applications SA), Becton Dickinson and Co, Nordion, Mevion Medical Systems, NTP RADIOISOTOPES, Mallinckrodt Plc, and Curium are some of the leading companies operating in the Europe radiation oncology market.

    Identical Market Reports with other Region/Countries

    The List of Companies - Europe Radiation Oncology Market

    1. Varian Medical Systems Inc.
    2. Elekta AB.
    3. Accuray Incorporated.
    4. IBA Worldwide (Ion Beam Applications SA).
    5. Becton Dickinson and Co.
    6. Nordion.
    7. Mevion Medical Systems.
    8. NTP RADIOISOTOPES.
    9. Mallinckrodt Plc.
    10. Curium.
    Frequently Asked Questions
    How big is the Europe Radiation Oncology Market?

    The Europe Radiation Oncology Market is valued at US$ 3,317.21 Million in 2023, it is projected to reach US$ 8,723.07 Million by 2031.

    What is the CAGR for Europe Radiation Oncology Market by (2023 - 2031)?

    As per our report Europe Radiation Oncology Market, the market size is valued at US$ 3,317.21 Million in 2023, projecting it to reach US$ 8,723.07 Million by 2031. This translates to a CAGR of approximately 12.8% during the forecast period.

    What segments are covered in this report?

    The Europe Radiation Oncology Market report typically cover these key segments-

    • Types (External Beam Radiation Therapy, Internal Beam Radiation Therapy)
    • Application (Breast Cancer, Prostate Cancer, Lung Cancer, Head & Neck Cancer, Cervical Cancer)

    What is the historic period, base year, and forecast period taken for Europe Radiation Oncology Market?

    The historic period, base year, and forecast period can vary slightly depending on the specific market research report. However, for the Europe Radiation Oncology Market report:

  • Historic Period : 2021-2022
  • Base Year : 2023
  • Forecast Period : 2024-2031
    • Who are the major players in Europe Radiation Oncology Market?

    The Europe Radiation Oncology Market is populated by several key players, each contributing to its growth and innovation. Some of the major players include:

  • Varian Medical Systems Inc.
  • Elekta AB.
  • Accuray Incorporated.
  • IBA Worldwide (Ion Beam Applications SA).
  • Becton Dickinson and Co.
  • Nordion.
  • Mevion Medical Systems.
  • NTP RADIOISOTOPES.
  • Mallinckrodt Plc.
  • Curium.
    • Who should buy this report?

    The Europe Radiation Oncology Market report is valuable for diverse stakeholders, including:

    • Investors: Provides insights for investment decisions pertaining to market growth, companies, or industry insights. Helps assess market attractiveness and potential returns.
    • Industry Players: Offers competitive intelligence, market sizing, and trend analysis to inform strategic planning, product development, and sales strategies.
    • Suppliers and Manufacturers: Helps understand market demand for components, materials, and services related to concerned industry.
    • Researchers and Consultants: Provides data and analysis for academic research, consulting projects, and market studies.
    • Financial Institutions: Helps assess risks and opportunities associated with financing or investing in the concerned market.

    Essentially, anyone involved in or considering involvement in the Europe Radiation Oncology Market value chain can benefit from the information contained in a comprehensive market report.

    europe-radiation-oncology-market